{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "86e0f6aa-c280-4b85-a0bb-4bb67620b6f9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import networkx as nx\n",
    "import matplotlib.pyplot as plt\n",
    "import requests\n",
    "import io\n",
    "import seaborn as sns\n",
    "from tqdm.notebook import tqdm\n",
    "import community as community_louvain\n",
    "import os\n",
    "from zipfile import ZipFile\n",
    "from scipy.stats import fisher_exact\n",
    "import numpy as np\n",
    "from statsmodels.stats.multitest import multipletests\n",
    "import random\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "78affb41-acd1-4a08-8370-e976cb8ecad3",
   "metadata": {},
   "outputs": [],
   "source": [
    "%run utility.ipynb"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "6bc28f83-3b61-48a9-b157-2ab9f31fd8e3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading BioGRID data\n",
      "Using file: BIOGRID-MV-Physical-4.4.245.tab2.txt\n",
      "Loaded 318015 human ppi-interactions\n",
      "\n",
      "Experimental System Distribution (Total: 318015 interactions):\n",
      "--------------------------------------------------------------------------------\n",
      "System Type                              |      Count | Percentage\n",
      "--------------------------------------------------------------------------------\n",
      "Affinity Capture-MS                      |    124,227 |     39.06%\n",
      "Affinity Capture-Western                 |     61,914 |     19.47%\n",
      "Proximity Label-MS                       |     28,720 |      9.03%\n",
      "Reconstituted Complex                    |     27,385 |      8.61%\n",
      "Co-fractionation                         |     22,161 |      6.97%\n",
      "Two-hybrid                               |     21,778 |      6.85%\n",
      "Biochemical Activity                     |      9,542 |      3.00%\n",
      "Cross-Linking-MS (XL-MS)                 |      8,267 |      2.60%\n",
      "Co-localization                          |      3,648 |      1.15%\n",
      "Protein-peptide                          |      1,788 |      0.56%\n",
      "Co-crystal Structure                     |      1,761 |      0.55%\n",
      "Affinity Capture-Luminescence            |      1,455 |      0.46%\n",
      "Co-purification                          |      1,423 |      0.45%\n",
      "FRET                                     |      1,257 |      0.40%\n",
      "Affinity Capture-RNA                     |      1,195 |      0.38%\n",
      "Far Western                              |        602 |      0.19%\n",
      "PCA                                      |        597 |      0.19%\n",
      "Protein-RNA                              |        295 |      0.09%\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>#BioGRID Interaction ID</th>\n",
       "      <th>Entrez Gene Interactor A</th>\n",
       "      <th>Entrez Gene Interactor B</th>\n",
       "      <th>BioGRID ID Interactor A</th>\n",
       "      <th>BioGRID ID Interactor B</th>\n",
       "      <th>Systematic Name Interactor A</th>\n",
       "      <th>Systematic Name Interactor B</th>\n",
       "      <th>Official Symbol Interactor A</th>\n",
       "      <th>Official Symbol Interactor B</th>\n",
       "      <th>Synonyms Interactor A</th>\n",
       "      <th>...</th>\n",
       "      <th>Pubmed ID</th>\n",
       "      <th>Organism Interactor A</th>\n",
       "      <th>Organism Interactor B</th>\n",
       "      <th>Throughput</th>\n",
       "      <th>Score</th>\n",
       "      <th>Modification</th>\n",
       "      <th>Phenotypes</th>\n",
       "      <th>Qualifications</th>\n",
       "      <th>Tags</th>\n",
       "      <th>Source Database</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>103</td>\n",
       "      <td>6416</td>\n",
       "      <td>2318</td>\n",
       "      <td>112315</td>\n",
       "      <td>108607</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>MAP2K4</td>\n",
       "      <td>FLNC</td>\n",
       "      <td>JNKK|JNKK1|MAPKK4|MEK4|MKK4|PRKMK4|SAPKK-1|SAP...</td>\n",
       "      <td>...</td>\n",
       "      <td>9006895</td>\n",
       "      <td>9606</td>\n",
       "      <td>9606</td>\n",
       "      <td>Low Throughput</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>BIOGRID</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>278</td>\n",
       "      <td>2624</td>\n",
       "      <td>5371</td>\n",
       "      <td>108894</td>\n",
       "      <td>111384</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>GATA2</td>\n",
       "      <td>PML</td>\n",
       "      <td>DCML|IMD21|MONOMAC|NFE1B</td>\n",
       "      <td>...</td>\n",
       "      <td>10938104</td>\n",
       "      <td>9606</td>\n",
       "      <td>9606</td>\n",
       "      <td>Low Throughput</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>BIOGRID</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>418</td>\n",
       "      <td>6118</td>\n",
       "      <td>6774</td>\n",
       "      <td>112038</td>\n",
       "      <td>112651</td>\n",
       "      <td>RP4-547C9.3</td>\n",
       "      <td>-</td>\n",
       "      <td>RPA2</td>\n",
       "      <td>STAT3</td>\n",
       "      <td>REPA2|RP-A p32|RP-A p34|RPA32</td>\n",
       "      <td>...</td>\n",
       "      <td>10875894</td>\n",
       "      <td>9606</td>\n",
       "      <td>9606</td>\n",
       "      <td>Low Throughput</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>BIOGRID</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>586</td>\n",
       "      <td>375</td>\n",
       "      <td>23163</td>\n",
       "      <td>106870</td>\n",
       "      <td>116775</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>ARF1</td>\n",
       "      <td>GGA3</td>\n",
       "      <td>-</td>\n",
       "      <td>...</td>\n",
       "      <td>10747089</td>\n",
       "      <td>9606</td>\n",
       "      <td>9606</td>\n",
       "      <td>Low Throughput</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>BIOGRID</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>612</td>\n",
       "      <td>377</td>\n",
       "      <td>23647</td>\n",
       "      <td>106872</td>\n",
       "      <td>117174</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>ARF3</td>\n",
       "      <td>ARFIP2</td>\n",
       "      <td>-</td>\n",
       "      <td>...</td>\n",
       "      <td>9038142</td>\n",
       "      <td>9606</td>\n",
       "      <td>9606</td>\n",
       "      <td>Low Throughput</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>BIOGRID</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 24 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   #BioGRID Interaction ID Entrez Gene Interactor A Entrez Gene Interactor B  \\\n",
       "0                      103                     6416                     2318   \n",
       "1                      278                     2624                     5371   \n",
       "2                      418                     6118                     6774   \n",
       "3                      586                      375                    23163   \n",
       "4                      612                      377                    23647   \n",
       "\n",
       "   BioGRID ID Interactor A  BioGRID ID Interactor B  \\\n",
       "0                   112315                   108607   \n",
       "1                   108894                   111384   \n",
       "2                   112038                   112651   \n",
       "3                   106870                   116775   \n",
       "4                   106872                   117174   \n",
       "\n",
       "  Systematic Name Interactor A Systematic Name Interactor B  \\\n",
       "0                            -                            -   \n",
       "1                            -                            -   \n",
       "2                  RP4-547C9.3                            -   \n",
       "3                            -                            -   \n",
       "4                            -                            -   \n",
       "\n",
       "  Official Symbol Interactor A Official Symbol Interactor B  \\\n",
       "0                       MAP2K4                         FLNC   \n",
       "1                        GATA2                          PML   \n",
       "2                         RPA2                        STAT3   \n",
       "3                         ARF1                         GGA3   \n",
       "4                         ARF3                       ARFIP2   \n",
       "\n",
       "                               Synonyms Interactor A  ... Pubmed ID  \\\n",
       "0  JNKK|JNKK1|MAPKK4|MEK4|MKK4|PRKMK4|SAPKK-1|SAP...  ...   9006895   \n",
       "1                           DCML|IMD21|MONOMAC|NFE1B  ...  10938104   \n",
       "2                      REPA2|RP-A p32|RP-A p34|RPA32  ...  10875894   \n",
       "3                                                  -  ...  10747089   \n",
       "4                                                  -  ...   9038142   \n",
       "\n",
       "  Organism Interactor A Organism Interactor B      Throughput  Score  \\\n",
       "0                  9606                  9606  Low Throughput      -   \n",
       "1                  9606                  9606  Low Throughput      -   \n",
       "2                  9606                  9606  Low Throughput      -   \n",
       "3                  9606                  9606  Low Throughput      -   \n",
       "4                  9606                  9606  Low Throughput      -   \n",
       "\n",
       "   Modification  Phenotypes Qualifications Tags Source Database  \n",
       "0             -           -              -    -         BIOGRID  \n",
       "1             -           -              -    -         BIOGRID  \n",
       "2             -           -              -    -         BIOGRID  \n",
       "3             -           -              -    -         BIOGRID  \n",
       "4             -           -              -    -         BIOGRID  \n",
       "\n",
       "[5 rows x 24 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Building network with 318015 physical interactions...\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ae3a9a45954b49519ee3b1c40905ee29",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "  0%|          | 0/318015 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Network created with 11553 nodes and 89993 edges\n",
      "  Interactions with missing symbols: 0\n",
      "  Self-interactions: 5931\n",
      "  Duplicate edges: 222091\n",
      "  Unique edges added: 89993\n",
      "  Sum: 318015\n",
      "\n",
      "=========================================\n",
      "Loading disease groups and their genes\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>gene</th>\n",
       "      <th>group_number</th>\n",
       "      <th>group_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>FGFR3</td>\n",
       "      <td>1</td>\n",
       "      <td>FGFR3 chondrodysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>COL2A1</td>\n",
       "      <td>2</td>\n",
       "      <td>Type 2 collagen disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>COL11A1</td>\n",
       "      <td>3</td>\n",
       "      <td>Type 11 collagen disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>COL11A2</td>\n",
       "      <td>3</td>\n",
       "      <td>Type 11 collagen disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>SLC26A2</td>\n",
       "      <td>4</td>\n",
       "      <td>Sulfation disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>599</th>\n",
       "      <td>GDF6</td>\n",
       "      <td>41</td>\n",
       "      <td>Defects in joint formation and synostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600</th>\n",
       "      <td>PITX1</td>\n",
       "      <td>41</td>\n",
       "      <td>Defects in joint formation and synostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>601</th>\n",
       "      <td>GSC</td>\n",
       "      <td>41</td>\n",
       "      <td>Defects in joint formation and synostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>602</th>\n",
       "      <td>HOXA11</td>\n",
       "      <td>41</td>\n",
       "      <td>Defects in joint formation and synostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>603</th>\n",
       "      <td>MECOM</td>\n",
       "      <td>41</td>\n",
       "      <td>Defects in joint formation and synostoses</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>604 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        gene  group_number                          group_description\n",
       "0      FGFR3             1                    FGFR3 chondrodysplasias\n",
       "1     COL2A1             2                  Type 2 collagen disorders\n",
       "2    COL11A1             3                 Type 11 collagen disorders\n",
       "3    COL11A2             3                 Type 11 collagen disorders\n",
       "4    SLC26A2             4                        Sulfation disorders\n",
       "..       ...           ...                                        ...\n",
       "599     GDF6            41  Defects in joint formation and synostoses\n",
       "600    PITX1            41  Defects in joint formation and synostoses\n",
       "601      GSC            41  Defects in joint formation and synostoses\n",
       "602   HOXA11            41  Defects in joint formation and synostoses\n",
       "603    MECOM            41  Defects in joint formation and synostoses\n",
       "\n",
       "[604 rows x 3 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total genes: 604\n",
      "Unique genes: 549\n",
      "\n",
      "Duplicate genes found:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>gene</th>\n",
       "      <th>group_number</th>\n",
       "      <th>group_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>ACTB</td>\n",
       "      <td>31</td>\n",
       "      <td>Overgrowth (tall stature) syndromes and segmen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>499</th>\n",
       "      <td>ACTB</td>\n",
       "      <td>35</td>\n",
       "      <td>Craniofacial dysostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>438</th>\n",
       "      <td>ALX4</td>\n",
       "      <td>33</td>\n",
       "      <td>Cleidocranial dysplasia and related disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>483</th>\n",
       "      <td>ALX4</td>\n",
       "      <td>35</td>\n",
       "      <td>Craniofacial dysostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>367</th>\n",
       "      <td>ANKH</td>\n",
       "      <td>27</td>\n",
       "      <td>Disorders of bone mineralisation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>ANKH</td>\n",
       "      <td>25</td>\n",
       "      <td>Osteosclerotic disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>588</th>\n",
       "      <td>BHLHA9</td>\n",
       "      <td>40</td>\n",
       "      <td>Polydactyly‐Syndactyly‐Triphalangism group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>567</th>\n",
       "      <td>BHLHA9</td>\n",
       "      <td>39</td>\n",
       "      <td>Split hand/foot with and without other manifes...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>BMPR1B</td>\n",
       "      <td>18</td>\n",
       "      <td>Brachydactylies (isolated)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>BMPR1B</td>\n",
       "      <td>16</td>\n",
       "      <td>Acromesomelic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>CANT1</td>\n",
       "      <td>5</td>\n",
       "      <td>Dysplasias with multiple joint dislocations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>CANT1</td>\n",
       "      <td>9</td>\n",
       "      <td>Pseudoachondroplasia and the multiple epiphyse...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>COL1A1</td>\n",
       "      <td>25</td>\n",
       "      <td>Osteosclerotic disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>COL1A1</td>\n",
       "      <td>26</td>\n",
       "      <td>Osteogenesis imperfecta and bone fragility group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>DNA2</td>\n",
       "      <td>21</td>\n",
       "      <td>Primordial dwarfism and slender bones group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>552</th>\n",
       "      <td>DNA2</td>\n",
       "      <td>38</td>\n",
       "      <td>Limb hypoplasia—reduction defects group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>452</th>\n",
       "      <td>ERF</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>ERF</td>\n",
       "      <td>19</td>\n",
       "      <td>Brachydactylies as part of syndromes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>EVC1</td>\n",
       "      <td>10</td>\n",
       "      <td>Skeletal disorders caused by abnormalities of ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>EVC1</td>\n",
       "      <td>35</td>\n",
       "      <td>Craniofacial dysostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>EVC2</td>\n",
       "      <td>35</td>\n",
       "      <td>Craniofacial dysostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>EVC2</td>\n",
       "      <td>10</td>\n",
       "      <td>Skeletal disorders caused by abnormalities of ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>EXT1</td>\n",
       "      <td>19</td>\n",
       "      <td>Brachydactylies as part of syndromes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>385</th>\n",
       "      <td>EXT1</td>\n",
       "      <td>30</td>\n",
       "      <td>Disorganized development of skeletal component...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>FBN1</td>\n",
       "      <td>17</td>\n",
       "      <td>Acromelic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399</th>\n",
       "      <td>FBN1</td>\n",
       "      <td>31</td>\n",
       "      <td>Overgrowth (tall stature) syndromes and segmen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>294</th>\n",
       "      <td>FGF23</td>\n",
       "      <td>25</td>\n",
       "      <td>Osteosclerotic disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>351</th>\n",
       "      <td>FGF23</td>\n",
       "      <td>27</td>\n",
       "      <td>Disorders of bone mineralisation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>568</th>\n",
       "      <td>FGFR1</td>\n",
       "      <td>39</td>\n",
       "      <td>Split hand/foot with and without other manifes...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>390</th>\n",
       "      <td>FGFR1</td>\n",
       "      <td>30</td>\n",
       "      <td>Disorganized development of skeletal component...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>440</th>\n",
       "      <td>FGFR1</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>FGFR2</td>\n",
       "      <td>20</td>\n",
       "      <td>Bent bones dysplasia group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>441</th>\n",
       "      <td>FGFR2</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>580</th>\n",
       "      <td>FGFR2</td>\n",
       "      <td>40</td>\n",
       "      <td>Polydactyly‐Syndactyly‐Triphalangism group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>FGFR3</td>\n",
       "      <td>31</td>\n",
       "      <td>Overgrowth (tall stature) syndromes and segmen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>442</th>\n",
       "      <td>FGFR3</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>581</th>\n",
       "      <td>FGFR3</td>\n",
       "      <td>40</td>\n",
       "      <td>Polydactyly‐Syndactyly‐Triphalangism group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>FGFR3</td>\n",
       "      <td>1</td>\n",
       "      <td>FGFR3 chondrodysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>GDF5</td>\n",
       "      <td>18</td>\n",
       "      <td>Brachydactylies (isolated)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>597</th>\n",
       "      <td>GDF5</td>\n",
       "      <td>41</td>\n",
       "      <td>Defects in joint formation and synostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>GDF5</td>\n",
       "      <td>16</td>\n",
       "      <td>Acromesomelic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>512</th>\n",
       "      <td>GDF6</td>\n",
       "      <td>36</td>\n",
       "      <td>Vertebral and costal dysostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>599</th>\n",
       "      <td>GDF6</td>\n",
       "      <td>41</td>\n",
       "      <td>Defects in joint formation and synostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>291</th>\n",
       "      <td>GJA1</td>\n",
       "      <td>25</td>\n",
       "      <td>Osteosclerotic disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>590</th>\n",
       "      <td>GJA1</td>\n",
       "      <td>40</td>\n",
       "      <td>Polydactyly‐Syndactyly‐Triphalangism group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>GLI1</td>\n",
       "      <td>10</td>\n",
       "      <td>Skeletal disorders caused by abnormalities of ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>573</th>\n",
       "      <td>GLI1</td>\n",
       "      <td>40</td>\n",
       "      <td>Polydactyly‐Syndactyly‐Triphalangism group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>388</th>\n",
       "      <td>GNAS</td>\n",
       "      <td>30</td>\n",
       "      <td>Disorganized development of skeletal component...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>GNAS</td>\n",
       "      <td>17</td>\n",
       "      <td>Acromelic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>HOXD13</td>\n",
       "      <td>18</td>\n",
       "      <td>Brachydactylies (isolated)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>591</th>\n",
       "      <td>HOXD13</td>\n",
       "      <td>40</td>\n",
       "      <td>Polydactyly‐Syndactyly‐Triphalangism group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>IHH</td>\n",
       "      <td>18</td>\n",
       "      <td>Brachydactylies (isolated)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>592</th>\n",
       "      <td>IHH</td>\n",
       "      <td>40</td>\n",
       "      <td>Polydactyly‐Syndactyly‐Triphalangism group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>IHH</td>\n",
       "      <td>17</td>\n",
       "      <td>Acromelic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>IL6ST</td>\n",
       "      <td>20</td>\n",
       "      <td>Bent bones dysplasia group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>IL6ST</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>261</th>\n",
       "      <td>LBR</td>\n",
       "      <td>23</td>\n",
       "      <td>Chondrodysplasia punctata (CDP) group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>LBR</td>\n",
       "      <td>13</td>\n",
       "      <td>Spondyloepi(meta)physeal dysplasias (SE(M)D)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>LMNA</td>\n",
       "      <td>19</td>\n",
       "      <td>Brachydactylies as part of syndromes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>375</th>\n",
       "      <td>LMNA</td>\n",
       "      <td>29</td>\n",
       "      <td>Osteolysis group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>303</th>\n",
       "      <td>LRP4</td>\n",
       "      <td>25</td>\n",
       "      <td>Osteosclerotic disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>585</th>\n",
       "      <td>LRP4</td>\n",
       "      <td>40</td>\n",
       "      <td>Polydactyly‐Syndactyly‐Triphalangism group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>336</th>\n",
       "      <td>LRP5</td>\n",
       "      <td>26</td>\n",
       "      <td>Osteogenesis imperfecta and bone fragility group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>301</th>\n",
       "      <td>LRP5</td>\n",
       "      <td>25</td>\n",
       "      <td>Osteosclerotic disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>LTBP3</td>\n",
       "      <td>17</td>\n",
       "      <td>Acromelic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>LTBP3</td>\n",
       "      <td>13</td>\n",
       "      <td>Spondyloepi(meta)physeal dysplasias (SE(M)D)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>MATN3</td>\n",
       "      <td>9</td>\n",
       "      <td>Pseudoachondroplasia and the multiple epiphyse...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>MATN3</td>\n",
       "      <td>13</td>\n",
       "      <td>Spondyloepi(meta)physeal dysplasias (SE(M)D)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>444</th>\n",
       "      <td>MSX2</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>439</th>\n",
       "      <td>MSX2</td>\n",
       "      <td>33</td>\n",
       "      <td>Cleidocranial dysplasia and related disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>596</th>\n",
       "      <td>NOG</td>\n",
       "      <td>41</td>\n",
       "      <td>Defects in joint formation and synostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>NOG</td>\n",
       "      <td>18</td>\n",
       "      <td>Brachydactylies (isolated)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>NPR2</td>\n",
       "      <td>31</td>\n",
       "      <td>Overgrowth (tall stature) syndromes and segmen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>NPR2</td>\n",
       "      <td>16</td>\n",
       "      <td>Acromesomelic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>382</th>\n",
       "      <td>PDGFRB</td>\n",
       "      <td>29</td>\n",
       "      <td>Osteolysis group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>425</th>\n",
       "      <td>PDGFRB</td>\n",
       "      <td>31</td>\n",
       "      <td>Overgrowth (tall stature) syndromes and segmen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600</th>\n",
       "      <td>PITX1</td>\n",
       "      <td>41</td>\n",
       "      <td>Defects in joint formation and synostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>543</th>\n",
       "      <td>PITX1</td>\n",
       "      <td>38</td>\n",
       "      <td>Limb hypoplasia—reduction defects group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>550</th>\n",
       "      <td>RECQL4</td>\n",
       "      <td>38</td>\n",
       "      <td>Limb hypoplasia—reduction defects group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>447</th>\n",
       "      <td>RECQL4</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>206</th>\n",
       "      <td>RNU4ATAC</td>\n",
       "      <td>21</td>\n",
       "      <td>Primordial dwarfism and slender bones group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>RNU4ATAC</td>\n",
       "      <td>9</td>\n",
       "      <td>Pseudoachondroplasia and the multiple epiphyse...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>ROR2</td>\n",
       "      <td>18</td>\n",
       "      <td>Brachydactylies (isolated)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>ROR2</td>\n",
       "      <td>15</td>\n",
       "      <td>Mesomelic and rhizo‐mesomelic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>454</th>\n",
       "      <td>RUNX2</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>RUNX2</td>\n",
       "      <td>11</td>\n",
       "      <td>Metaphyseal dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>433</th>\n",
       "      <td>RUNX2</td>\n",
       "      <td>33</td>\n",
       "      <td>Cleidocranial dysplasia and related disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>SBDS</td>\n",
       "      <td>11</td>\n",
       "      <td>Metaphyseal dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>SBDS</td>\n",
       "      <td>14</td>\n",
       "      <td>Severe spondylodysplastic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>SMO</td>\n",
       "      <td>10</td>\n",
       "      <td>Skeletal disorders caused by abnormalities of ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>463</th>\n",
       "      <td>SMO</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>575</th>\n",
       "      <td>SMO</td>\n",
       "      <td>40</td>\n",
       "      <td>Polydactyly‐Syndactyly‐Triphalangism group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331</th>\n",
       "      <td>SP7</td>\n",
       "      <td>26</td>\n",
       "      <td>Osteogenesis imperfecta and bone fragility group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>SP7</td>\n",
       "      <td>25</td>\n",
       "      <td>Osteosclerotic disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>531</th>\n",
       "      <td>TBX4</td>\n",
       "      <td>38</td>\n",
       "      <td>Limb hypoplasia—reduction defects group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>526</th>\n",
       "      <td>TBX4</td>\n",
       "      <td>37</td>\n",
       "      <td>Patellar dysostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>374</th>\n",
       "      <td>TNFRSF11A</td>\n",
       "      <td>29</td>\n",
       "      <td>Osteolysis group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>TNFRSF11A</td>\n",
       "      <td>24</td>\n",
       "      <td>Osteopetrosis and related osteoclast disorders</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>TRIP11</td>\n",
       "      <td>14</td>\n",
       "      <td>Severe spondylodysplastic dysplasias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>TRIP11</td>\n",
       "      <td>12</td>\n",
       "      <td>Spondylometaphyseal dysplasias (SMD)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>486</th>\n",
       "      <td>TWIST1</td>\n",
       "      <td>35</td>\n",
       "      <td>Craniofacial dysostoses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>445</th>\n",
       "      <td>TWIST1</td>\n",
       "      <td>34</td>\n",
       "      <td>Syndromes featuring craniosynostosis</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          gene  group_number  \\\n",
       "426       ACTB            31   \n",
       "499       ACTB            35   \n",
       "438       ALX4            33   \n",
       "483       ALX4            35   \n",
       "367       ANKH            27   \n",
       "290       ANKH            25   \n",
       "588     BHLHA9            40   \n",
       "567     BHLHA9            39   \n",
       "166     BMPR1B            18   \n",
       "151     BMPR1B            16   \n",
       "14       CANT1             5   \n",
       "35       CANT1             9   \n",
       "285     COL1A1            25   \n",
       "313     COL1A1            26   \n",
       "211       DNA2            21   \n",
       "552       DNA2            38   \n",
       "452        ERF            34   \n",
       "187        ERF            19   \n",
       "64        EVC1            10   \n",
       "494       EVC1            35   \n",
       "495       EVC2            35   \n",
       "65        EVC2            10   \n",
       "175       EXT1            19   \n",
       "385       EXT1            30   \n",
       "154       FBN1            17   \n",
       "399       FBN1            31   \n",
       "294      FGF23            25   \n",
       "351      FGF23            27   \n",
       "568      FGFR1            39   \n",
       "390      FGFR1            30   \n",
       "440      FGFR1            34   \n",
       "199      FGFR2            20   \n",
       "441      FGFR2            34   \n",
       "580      FGFR2            40   \n",
       "424      FGFR3            31   \n",
       "442      FGFR3            34   \n",
       "581      FGFR3            40   \n",
       "0        FGFR3             1   \n",
       "168       GDF5            18   \n",
       "597       GDF5            41   \n",
       "150       GDF5            16   \n",
       "512       GDF6            36   \n",
       "599       GDF6            41   \n",
       "291       GJA1            25   \n",
       "590       GJA1            40   \n",
       "66        GLI1            10   \n",
       "573       GLI1            40   \n",
       "388       GNAS            30   \n",
       "162       GNAS            17   \n",
       "171     HOXD13            18   \n",
       "591     HOXD13            40   \n",
       "165        IHH            18   \n",
       "592        IHH            40   \n",
       "152        IHH            17   \n",
       "197      IL6ST            20   \n",
       "457      IL6ST            34   \n",
       "261        LBR            23   \n",
       "125        LBR            13   \n",
       "194       LMNA            19   \n",
       "375       LMNA            29   \n",
       "303       LRP4            25   \n",
       "585       LRP4            40   \n",
       "336       LRP5            26   \n",
       "301       LRP5            25   \n",
       "155      LTBP3            17   \n",
       "120      LTBP3            13   \n",
       "34       MATN3             9   \n",
       "101      MATN3            13   \n",
       "444       MSX2            34   \n",
       "439       MSX2            33   \n",
       "596        NOG            41   \n",
       "170        NOG            18   \n",
       "422       NPR2            31   \n",
       "148       NPR2            16   \n",
       "382     PDGFRB            29   \n",
       "425     PDGFRB            31   \n",
       "600      PITX1            41   \n",
       "543      PITX1            38   \n",
       "550     RECQL4            38   \n",
       "447     RECQL4            34   \n",
       "206   RNU4ATAC            21   \n",
       "39    RNU4ATAC             9   \n",
       "169       ROR2            18   \n",
       "140       ROR2            15   \n",
       "454      RUNX2            34   \n",
       "89       RUNX2            11   \n",
       "433      RUNX2            33   \n",
       "83        SBDS            11   \n",
       "130       SBDS            14   \n",
       "67         SMO            10   \n",
       "463        SMO            34   \n",
       "575        SMO            40   \n",
       "331        SP7            26   \n",
       "304        SP7            25   \n",
       "531       TBX4            38   \n",
       "526       TBX4            37   \n",
       "374  TNFRSF11A            29   \n",
       "270  TNFRSF11A            24   \n",
       "127     TRIP11            14   \n",
       "91      TRIP11            12   \n",
       "486     TWIST1            35   \n",
       "445     TWIST1            34   \n",
       "\n",
       "                                     group_description  \n",
       "426  Overgrowth (tall stature) syndromes and segmen...  \n",
       "499                            Craniofacial dysostoses  \n",
       "438      Cleidocranial dysplasia and related disorders  \n",
       "483                            Craniofacial dysostoses  \n",
       "367                   Disorders of bone mineralisation  \n",
       "290                           Osteosclerotic disorders  \n",
       "588         Polydactyly‐Syndactyly‐Triphalangism group  \n",
       "567  Split hand/foot with and without other manifes...  \n",
       "166                         Brachydactylies (isolated)  \n",
       "151                           Acromesomelic dysplasias  \n",
       "14         Dysplasias with multiple joint dislocations  \n",
       "35   Pseudoachondroplasia and the multiple epiphyse...  \n",
       "285                           Osteosclerotic disorders  \n",
       "313   Osteogenesis imperfecta and bone fragility group  \n",
       "211        Primordial dwarfism and slender bones group  \n",
       "552            Limb hypoplasia—reduction defects group  \n",
       "452               Syndromes featuring craniosynostosis  \n",
       "187               Brachydactylies as part of syndromes  \n",
       "64   Skeletal disorders caused by abnormalities of ...  \n",
       "494                            Craniofacial dysostoses  \n",
       "495                            Craniofacial dysostoses  \n",
       "65   Skeletal disorders caused by abnormalities of ...  \n",
       "175               Brachydactylies as part of syndromes  \n",
       "385  Disorganized development of skeletal component...  \n",
       "154                               Acromelic dysplasias  \n",
       "399  Overgrowth (tall stature) syndromes and segmen...  \n",
       "294                           Osteosclerotic disorders  \n",
       "351                   Disorders of bone mineralisation  \n",
       "568  Split hand/foot with and without other manifes...  \n",
       "390  Disorganized development of skeletal component...  \n",
       "440               Syndromes featuring craniosynostosis  \n",
       "199                         Bent bones dysplasia group  \n",
       "441               Syndromes featuring craniosynostosis  \n",
       "580         Polydactyly‐Syndactyly‐Triphalangism group  \n",
       "424  Overgrowth (tall stature) syndromes and segmen...  \n",
       "442               Syndromes featuring craniosynostosis  \n",
       "581         Polydactyly‐Syndactyly‐Triphalangism group  \n",
       "0                              FGFR3 chondrodysplasias  \n",
       "168                         Brachydactylies (isolated)  \n",
       "597          Defects in joint formation and synostoses  \n",
       "150                           Acromesomelic dysplasias  \n",
       "512                    Vertebral and costal dysostoses  \n",
       "599          Defects in joint formation and synostoses  \n",
       "291                           Osteosclerotic disorders  \n",
       "590         Polydactyly‐Syndactyly‐Triphalangism group  \n",
       "66   Skeletal disorders caused by abnormalities of ...  \n",
       "573         Polydactyly‐Syndactyly‐Triphalangism group  \n",
       "388  Disorganized development of skeletal component...  \n",
       "162                               Acromelic dysplasias  \n",
       "171                         Brachydactylies (isolated)  \n",
       "591         Polydactyly‐Syndactyly‐Triphalangism group  \n",
       "165                         Brachydactylies (isolated)  \n",
       "592         Polydactyly‐Syndactyly‐Triphalangism group  \n",
       "152                               Acromelic dysplasias  \n",
       "197                         Bent bones dysplasia group  \n",
       "457               Syndromes featuring craniosynostosis  \n",
       "261              Chondrodysplasia punctata (CDP) group  \n",
       "125       Spondyloepi(meta)physeal dysplasias (SE(M)D)  \n",
       "194               Brachydactylies as part of syndromes  \n",
       "375                                   Osteolysis group  \n",
       "303                           Osteosclerotic disorders  \n",
       "585         Polydactyly‐Syndactyly‐Triphalangism group  \n",
       "336   Osteogenesis imperfecta and bone fragility group  \n",
       "301                           Osteosclerotic disorders  \n",
       "155                               Acromelic dysplasias  \n",
       "120       Spondyloepi(meta)physeal dysplasias (SE(M)D)  \n",
       "34   Pseudoachondroplasia and the multiple epiphyse...  \n",
       "101       Spondyloepi(meta)physeal dysplasias (SE(M)D)  \n",
       "444               Syndromes featuring craniosynostosis  \n",
       "439      Cleidocranial dysplasia and related disorders  \n",
       "596          Defects in joint formation and synostoses  \n",
       "170                         Brachydactylies (isolated)  \n",
       "422  Overgrowth (tall stature) syndromes and segmen...  \n",
       "148                           Acromesomelic dysplasias  \n",
       "382                                   Osteolysis group  \n",
       "425  Overgrowth (tall stature) syndromes and segmen...  \n",
       "600          Defects in joint formation and synostoses  \n",
       "543            Limb hypoplasia—reduction defects group  \n",
       "550            Limb hypoplasia—reduction defects group  \n",
       "447               Syndromes featuring craniosynostosis  \n",
       "206        Primordial dwarfism and slender bones group  \n",
       "39   Pseudoachondroplasia and the multiple epiphyse...  \n",
       "169                         Brachydactylies (isolated)  \n",
       "140           Mesomelic and rhizo‐mesomelic dysplasias  \n",
       "454               Syndromes featuring craniosynostosis  \n",
       "89                              Metaphyseal dysplasias  \n",
       "433      Cleidocranial dysplasia and related disorders  \n",
       "83                              Metaphyseal dysplasias  \n",
       "130               Severe spondylodysplastic dysplasias  \n",
       "67   Skeletal disorders caused by abnormalities of ...  \n",
       "463               Syndromes featuring craniosynostosis  \n",
       "575         Polydactyly‐Syndactyly‐Triphalangism group  \n",
       "331   Osteogenesis imperfecta and bone fragility group  \n",
       "304                           Osteosclerotic disorders  \n",
       "531            Limb hypoplasia—reduction defects group  \n",
       "526                                Patellar dysostoses  \n",
       "374                                   Osteolysis group  \n",
       "270     Osteopetrosis and related osteoclast disorders  \n",
       "127               Severe spondylodysplastic dysplasias  \n",
       "91                Spondylometaphyseal dysplasias (SMD)  \n",
       "486                            Craniofacial dysostoses  \n",
       "445               Syndromes featuring craniosynostosis  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Load BioGRID data\n",
    "biogrid_zip_file = 'BIOGRID-MV-Physical-4.4.245.tab2.zip'\n",
    "biogrid_df = load_biogrid_data(biogrid_zip_file)\n",
    "display(biogrid_df.head())\n",
    "\n",
    "# Create PPI network\n",
    "ppi_network = create_ppi_network(biogrid_df, interaction_type='physical')\n",
    "\n",
    "# Load disease groups\n",
    "disease_groups_file = 'bones_disease_genes.csv'\n",
    "print(\"\\n=========================================\")\n",
    "print(\"Loading disease groups and their genes\")\n",
    "disease_df = pd.read_csv(disease_groups_file, sep='\\t')\n",
    "display(disease_df)\n",
    "# Check if all genes are unique\n",
    "total_genes = len(disease_df['gene'])\n",
    "unique_genes = len(disease_df['gene'].unique())\n",
    "print(f\"Total genes: {total_genes}\")\n",
    "print(f\"Unique genes: {unique_genes}\")\n",
    "# If there are duplicates, show them\n",
    "if total_genes != unique_genes:\n",
    "    duplicates = disease_df[disease_df['gene'].duplicated(keep=False)].sort_values('gene')\n",
    "    print(f\"\\nDuplicate genes found:\")\n",
    "    with pd.option_context('display.max_rows', None):\n",
    "        display(duplicates)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "83b1e045-9071-45f5-91f1-85effc06248e",
   "metadata": {},
   "outputs": [],
   "source": [
    "def detect_global_communities_and_analyze_disease_group(G, communities, diseases_df, target_group_number,\n",
    "                                                        gene_column=\"gene\", \n",
    "                                                        group_number_column=\"group_number\", \n",
    "                                                        group_description_column=\"group_description\"):\n",
    "    \"\"\"\n",
    "    Detect communities in the whole PPI network and analyzes how genes from a specific disease group\n",
    "    are distributed across these communities.\n",
    "    \n",
    "    Parameters:\n",
    "    G (networkx.Graph): Full PPI network\n",
    "    communities: List of communities (sets of proteins)\n",
    "    diseases_df (pandas.DataFrame): DataFrame containing genes for multiple disease groups\n",
    "    target_group_number (int): Specific disease group number to analyze\n",
    "    gene_column (str): Column name in DataFrame containing gene symbols\n",
    "    group_number_column (str): Column name containing group numbers\n",
    "    group_description_column (str): Column name containing group descriptions\n",
    "    \n",
    "    Returns:\n",
    "    pandas.DataFrame: Community statistics with enrichment results for the target group\n",
    "    \"\"\"\n",
    "    # Check if required columns exist\n",
    "    required_columns = [gene_column, group_number_column, group_description_column]\n",
    "    missing_columns = [col for col in required_columns if col not in diseases_df.columns]\n",
    "    if missing_columns:\n",
    "        print(f\"Missing columns: {', '.join(missing_columns)}\")\n",
    "        print(f\"Available columns: {', '.join(diseases_df.columns)}\")\n",
    "        return None\n",
    "    \n",
    "    # Check if DataFrame is empty\n",
    "    if diseases_df.empty:\n",
    "        print(\"Empty DataFrame provided\")\n",
    "        return None\n",
    "    \n",
    "    # Filter for target group\n",
    "    target_group_df = diseases_df[diseases_df[group_number_column] == target_group_number]\n",
    "    if target_group_df.empty:\n",
    "        print(f\"No genes found for group number {target_group_number}\")\n",
    "        available_groups = diseases_df[group_number_column].unique()\n",
    "        print(f\"Available groups: {sorted(available_groups)}\")\n",
    "        return None\n",
    "    \n",
    "    # Get group information\n",
    "    group_description = target_group_df[group_description_column].iloc[0]\n",
    "    \n",
    "    # Extract genes for target group\n",
    "    genes_of_interest = set(target_group_df[gene_column].dropna().unique())\n",
    "    genes_in_network = genes_of_interest.intersection(set(G.nodes()))\n",
    "    \n",
    "    print(f\"Analyzing disease group {target_group_number}: {group_description}\")\n",
    "    print(f\"Loaded {len(genes_of_interest)} genes from group\")\n",
    "    print(f\"Found {len(genes_in_network)} of these genes in the network\")\n",
    "    \n",
    "    if len(genes_in_network) == 0:\n",
    "        print(\"No genes from this group found in the network\")\n",
    "        return None\n",
    "    \n",
    "    # Create statistics about communities for the target disease group\n",
    "    community_stats = []\n",
    "    for i, community in enumerate(communities):\n",
    "        size = len(community)\n",
    "        # Find genes from target group in this community\n",
    "        target_genes_in_community = community.intersection(genes_in_network)\n",
    "        community_stats.append({\n",
    "            'Community_ID': i,\n",
    "            'Size': size,\n",
    "            'Target_Group_Genes': len(target_genes_in_community),\n",
    "            'Percentage_Of_Community': (len(target_genes_in_community) / size) * 100 if size > 0 else 0,\n",
    "            'Percentage_Of_Target_Group': (len(target_genes_in_community) / len(genes_in_network)) * 100 if len(genes_in_network) > 0 else 0,\n",
    "            'Target_Genes_List': list(target_genes_in_community)\n",
    "        })\n",
    "    \n",
    "    # Convert to DataFrame\n",
    "    stats_df = pd.DataFrame(community_stats)\n",
    "    \n",
    "    # Calculate Fisher's exact test for enrichment of target group in each community\n",
    "    total_nodes = G.number_of_nodes()\n",
    "    total_target_genes = len(genes_in_network)\n",
    "    \n",
    "    p_values = []\n",
    "    odds_ratios = []\n",
    "    \n",
    "    for _, row in stats_df.iterrows():\n",
    "        # Build contingency table\n",
    "        a = row['Target_Group_Genes']  # Target group genes in community\n",
    "        b = row['Size'] - a  # Other genes in community\n",
    "        c = total_target_genes - a  # Target group genes outside community\n",
    "        d = total_nodes - total_target_genes - b  # Other genes outside community\n",
    "        \n",
    "        # Skip communities with no target genes\n",
    "        if a == 0:\n",
    "            p_values.append(1.0)\n",
    "            odds_ratios.append(0.0)\n",
    "            continue\n",
    "        \n",
    "        table = np.array([[a, b], [c, d]])\n",
    "        # Test for overrepresentation\n",
    "        odds_ratio, p_value = fisher_exact(table, alternative='greater')\n",
    "        p_values.append(p_value)\n",
    "        odds_ratios.append(odds_ratio)\n",
    "    \n",
    "    # Add to DataFrame\n",
    "    stats_df['Enrichment_P_Value'] = p_values\n",
    "    stats_df['Odds_Ratio'] = odds_ratios\n",
    "    \n",
    "    # Apply Benjamini-Hochberg correction\n",
    "    if len(p_values) > 0:\n",
    "        _, corrected_p_values, _, _ = multipletests(p_values, method='fdr_bh')\n",
    "        stats_df['Adjusted_P_Value'] = corrected_p_values\n",
    "    \n",
    "    # Sort by enrichment significance\n",
    "    stats_df = stats_df.sort_values('Adjusted_P_Value')\n",
    "    \n",
    "    # Identify significantly enriched communities\n",
    "    enriched_communities = stats_df[stats_df['Adjusted_P_Value'] < 0.05]['Community_ID'].tolist()\n",
    "    print(f\"Found {len(enriched_communities)} significantly enriched communities for disease group {target_group_number}\")\n",
    "    \n",
    "    return stats_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "b9406d6f-960e-476d-8ba7-d4707a23ec0c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detecting communities in the PPI network...\n",
      "Detected 96 communities in the ppi network graph\n",
      "==================================================\n",
      "Analyzing disease group 1: FGFR3 chondrodysplasias\n",
      "Loaded 1 genes from group\n",
      "Found 1 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 1\n",
      "==================================================\n",
      "Analyzing disease group 2: Type 2 collagen disorders\n",
      "Loaded 1 genes from group\n",
      "Found 1 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 2\n",
      "==================================================\n",
      "Analyzing disease group 3: Type 11 collagen disorders\n",
      "Loaded 2 genes from group\n",
      "Found 0 of these genes in the network\n",
      "No genes from this group found in the network\n",
      "==================================================\n",
      "Analyzing disease group 4: Sulfation disorders\n",
      "Loaded 9 genes from group\n",
      "Found 4 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 4\n",
      "==================================================\n",
      "Analyzing disease group 5: Dysplasias with multiple joint dislocations\n",
      "Loaded 9 genes from group\n",
      "Found 6 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 5\n",
      "==================================================\n",
      "Analyzing disease group 6: Filamins and related disorders\n",
      "Loaded 7 genes from group\n",
      "Found 4 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 6\n",
      "==================================================\n",
      "Analyzing disease group 7: Proteoglycan core proteins disorders\n",
      "Loaded 3 genes from group\n",
      "Found 2 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 7\n",
      "==================================================\n",
      "Analyzing disease group 8: TRPV4 disorders\n",
      "Loaded 1 genes from group\n",
      "Found 1 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 8\n",
      "==================================================\n",
      "Analyzing disease group 9: Pseudoachondroplasia and the multiple epiphyseal dysplasias\n",
      "Loaded 7 genes from group\n",
      "Found 3 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 9\n",
      "==================================================\n",
      "Analyzing disease group 10: Skeletal disorders caused by abnormalities of cilia or ciliary signaling\n",
      "Loaded 39 genes from group\n",
      "Found 32 of these genes in the network\n",
      "Found 1 significantly enriched communities for disease group 10\n",
      "==================================================\n",
      "Analyzing disease group 11: Metaphyseal dysplasias\n",
      "Loaded 11 genes from group\n",
      "Found 6 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 11\n",
      "==================================================\n",
      "Analyzing disease group 12: Spondylometaphyseal dysplasias (SMD)\n",
      "Loaded 6 genes from group\n",
      "Found 4 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 12\n",
      "==================================================\n",
      "Analyzing disease group 13: Spondyloepi(meta)physeal dysplasias (SE(M)D)\n",
      "Loaded 31 genes from group\n",
      "Found 23 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 13\n",
      "==================================================\n",
      "Analyzing disease group 14: Severe spondylodysplastic dysplasias\n",
      "Loaded 7 genes from group\n",
      "Found 6 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 14\n",
      "==================================================\n",
      "Analyzing disease group 15: Mesomelic and rhizo‐mesomelic dysplasias\n",
      "Loaded 14 genes from group\n",
      "Found 9 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 15\n",
      "==================================================\n",
      "Analyzing disease group 16: Acromesomelic dysplasias\n",
      "Loaded 4 genes from group\n",
      "Found 3 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 16\n",
      "==================================================\n",
      "Analyzing disease group 17: Acromelic dysplasias\n",
      "Loaded 13 genes from group\n",
      "Found 6 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 17\n",
      "==================================================\n",
      "Analyzing disease group 18: Brachydactylies (isolated)\n",
      "Loaded 9 genes from group\n",
      "Found 5 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 18\n",
      "==================================================\n",
      "Analyzing disease group 19: Brachydactylies as part of syndromes\n",
      "Loaded 21 genes from group\n",
      "Found 17 of these genes in the network\n",
      "Found 1 significantly enriched communities for disease group 19\n",
      "==================================================\n",
      "Analyzing disease group 20: Bent bones dysplasia group\n",
      "Loaded 6 genes from group\n",
      "Found 6 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 20\n",
      "==================================================\n",
      "Analyzing disease group 21: Primordial dwarfism and slender bones group\n",
      "Loaded 32 genes from group\n",
      "Found 29 of these genes in the network\n",
      "Found 1 significantly enriched communities for disease group 21\n",
      "==================================================\n",
      "Analyzing disease group 22: Lysosomal storage diseases with skeletal involvement\n",
      "Loaded 24 genes from group\n",
      "Found 12 of these genes in the network\n",
      "Found 1 significantly enriched communities for disease group 22\n",
      "==================================================\n",
      "Analyzing disease group 23: Chondrodysplasia punctata (CDP) group\n",
      "Loaded 10 genes from group\n",
      "Found 7 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 23\n",
      "==================================================\n",
      "Analyzing disease group 24: Osteopetrosis and related osteoclast disorders\n",
      "Loaded 16 genes from group\n",
      "Found 12 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 24\n",
      "==================================================\n",
      "Analyzing disease group 25: Osteosclerotic disorders\n",
      "Loaded 30 genes from group\n",
      "Found 19 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 25\n",
      "==================================================\n",
      "Analyzing disease group 26: Osteogenesis imperfecta and bone fragility group\n",
      "Loaded 36 genes from group\n",
      "Found 26 of these genes in the network\n",
      "Found 1 significantly enriched communities for disease group 26\n",
      "==================================================\n",
      "Analyzing disease group 27: Disorders of bone mineralisation\n",
      "Loaded 22 genes from group\n",
      "Found 14 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 27\n",
      "==================================================\n",
      "Analyzing disease group 28: Skeletal disorders of the parathyroid hormone signaling cascade\n",
      "Loaded 3 genes from group\n",
      "Found 2 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 28\n",
      "==================================================\n",
      "Analyzing disease group 29: Osteolysis group\n",
      "Loaded 11 genes from group\n",
      "Found 10 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 29\n",
      "==================================================\n",
      "Analyzing disease group 30: Disorganized development of skeletal components group\n",
      "Loaded 14 genes from group\n",
      "Found 13 of these genes in the network\n",
      "Found 2 significantly enriched communities for disease group 30\n",
      "==================================================\n",
      "Analyzing disease group 31: Overgrowth (tall stature) syndromes and segmental overgrowth\n",
      "Loaded 28 genes from group\n",
      "Found 25 of these genes in the network\n",
      "Found 1 significantly enriched communities for disease group 31\n",
      "==================================================\n",
      "Analyzing disease group 32: Genetic inflammatory or rheumatoid‐like osteoarthropathies\n",
      "Loaded 6 genes from group\n",
      "Found 2 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 32\n",
      "==================================================\n",
      "Analyzing disease group 33: Cleidocranial dysplasia and related disorders\n",
      "Loaded 7 genes from group\n",
      "Found 5 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 33\n",
      "==================================================\n",
      "Analyzing disease group 34: Syndromes featuring craniosynostosis\n",
      "Loaded 31 genes from group\n",
      "Found 27 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 34\n",
      "==================================================\n",
      "Analyzing disease group 35: Craniofacial dysostoses\n",
      "Loaded 33 genes from group\n",
      "Found 24 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 35\n",
      "==================================================\n",
      "Analyzing disease group 36: Vertebral and costal dysostoses\n",
      "Loaded 22 genes from group\n",
      "Found 10 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 36\n",
      "==================================================\n",
      "Analyzing disease group 37: Patellar dysostoses\n",
      "Loaded 3 genes from group\n",
      "Found 2 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 37\n",
      "==================================================\n",
      "Analyzing disease group 38: Limb hypoplasia—reduction defects group\n",
      "Loaded 31 genes from group\n",
      "Found 21 of these genes in the network\n",
      "Found 1 significantly enriched communities for disease group 38\n",
      "==================================================\n",
      "Analyzing disease group 39: Split hand/foot with and without other manifestations\n",
      "Loaded 12 genes from group\n",
      "Found 6 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 39\n",
      "==================================================\n",
      "Analyzing disease group 40: Polydactyly‐Syndactyly‐Triphalangism group\n",
      "Loaded 24 genes from group\n",
      "Found 15 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 40\n",
      "==================================================\n",
      "Analyzing disease group 41: Defects in joint formation and synostoses\n",
      "Loaded 8 genes from group\n",
      "Found 5 of these genes in the network\n",
      "Found 0 significantly enriched communities for disease group 41\n",
      "\n",
      "============================================================\n",
      "RESULTS AFTER GLOBAL P-VALUE CORRECTION\n",
      "============================================================\n",
      "\n",
      "GROUP 1: No enriched communities\n",
      "\n",
      "GROUP 2: No enriched communities\n",
      "\n",
      "GROUP 4: No enriched communities\n",
      "\n",
      "GROUP 5: No enriched communities\n",
      "\n",
      "GROUP 6: No enriched communities\n",
      "\n",
      "GROUP 7: No enriched communities\n",
      "\n",
      "GROUP 8: No enriched communities\n",
      "\n",
      "GROUP 9: No enriched communities\n",
      "\n",
      "GROUP 10 - Enriched communities:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Community_ID</th>\n",
       "      <th>Size</th>\n",
       "      <th>Target_Group_Genes</th>\n",
       "      <th>Global_Adjusted_P_Value</th>\n",
       "      <th>Odds_Ratio</th>\n",
       "      <th>Target_Genes_List</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>7</td>\n",
       "      <td>560</td>\n",
       "      <td>21</td>\n",
       "      <td>5.192245e-17</td>\n",
       "      <td>38.897285</td>\n",
       "      <td>[IFT172, IFT52, IFT81, PRKACB, IFT122, RPGRIP1...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Community_ID  Size  Target_Group_Genes  Global_Adjusted_P_Value  \\\n",
       "7             7   560                  21             5.192245e-17   \n",
       "\n",
       "   Odds_Ratio                                  Target_Genes_List  \n",
       "7   38.897285  [IFT172, IFT52, IFT81, PRKACB, IFT122, RPGRIP1...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "GROUP 11: No enriched communities\n",
      "\n",
      "GROUP 12: No enriched communities\n",
      "\n",
      "GROUP 13: No enriched communities\n",
      "\n",
      "GROUP 14: No enriched communities\n",
      "\n",
      "GROUP 15: No enriched communities\n",
      "\n",
      "GROUP 16: No enriched communities\n",
      "\n",
      "GROUP 17: No enriched communities\n",
      "\n",
      "GROUP 18: No enriched communities\n",
      "\n",
      "GROUP 19 - Enriched communities:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Community_ID</th>\n",
       "      <th>Size</th>\n",
       "      <th>Target_Group_Genes</th>\n",
       "      <th>Global_Adjusted_P_Value</th>\n",
       "      <th>Odds_Ratio</th>\n",
       "      <th>Target_Genes_List</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>53</td>\n",
       "      <td>1687</td>\n",
       "      <td>10</td>\n",
       "      <td>0.029959</td>\n",
       "      <td>8.398501</td>\n",
       "      <td>[ARID1A, SMARCA4, SMARCB1, TRPS1, SMARCE1, MYC...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Community_ID  Size  Target_Group_Genes  Global_Adjusted_P_Value  \\\n",
       "53            53  1687                  10                 0.029959   \n",
       "\n",
       "    Odds_Ratio                                  Target_Genes_List  \n",
       "53    8.398501  [ARID1A, SMARCA4, SMARCB1, TRPS1, SMARCE1, MYC...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "GROUP 20: No enriched communities\n",
      "\n",
      "GROUP 21 - Enriched communities:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Community_ID</th>\n",
       "      <th>Size</th>\n",
       "      <th>Target_Group_Genes</th>\n",
       "      <th>Global_Adjusted_P_Value</th>\n",
       "      <th>Odds_Ratio</th>\n",
       "      <th>Target_Genes_List</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>1345</td>\n",
       "      <td>12</td>\n",
       "      <td>0.034113</td>\n",
       "      <td>5.396584</td>\n",
       "      <td>[ORC4, DONSON, ORC6, MCM5, DNA2, ORC1, TBCE, M...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Community_ID  Size  Target_Group_Genes  Global_Adjusted_P_Value  \\\n",
       "3             3  1345                  12                 0.034113   \n",
       "\n",
       "   Odds_Ratio                                  Target_Genes_List  \n",
       "3    5.396584  [ORC4, DONSON, ORC6, MCM5, DNA2, ORC1, TBCE, M...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "GROUP 22 - Enriched communities:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Community_ID</th>\n",
       "      <th>Size</th>\n",
       "      <th>Target_Group_Genes</th>\n",
       "      <th>Global_Adjusted_P_Value</th>\n",
       "      <th>Odds_Ratio</th>\n",
       "      <th>Target_Genes_List</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>1345</td>\n",
       "      <td>9</td>\n",
       "      <td>0.000777</td>\n",
       "      <td>22.915419</td>\n",
       "      <td>[IDUA, GBA, GNS, ARSK, GUSB, MAN2B1, AGA, SGSH...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Community_ID  Size  Target_Group_Genes  Global_Adjusted_P_Value  \\\n",
       "3             3  1345                   9                 0.000777   \n",
       "\n",
       "   Odds_Ratio                                  Target_Genes_List  \n",
       "3   22.915419  [IDUA, GBA, GNS, ARSK, GUSB, MAN2B1, AGA, SGSH...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "GROUP 23: No enriched communities\n",
      "\n",
      "GROUP 24: No enriched communities\n",
      "\n",
      "GROUP 25: No enriched communities\n",
      "\n",
      "GROUP 26: No enriched communities\n",
      "\n",
      "GROUP 27: No enriched communities\n",
      "\n",
      "GROUP 28: No enriched communities\n",
      "\n",
      "GROUP 29: No enriched communities\n",
      "\n",
      "GROUP 30: No enriched communities\n",
      "\n",
      "GROUP 31 - Enriched communities:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Community_ID</th>\n",
       "      <th>Size</th>\n",
       "      <th>Target_Group_Genes</th>\n",
       "      <th>Global_Adjusted_P_Value</th>\n",
       "      <th>Odds_Ratio</th>\n",
       "      <th>Target_Genes_List</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>25</td>\n",
       "      <td>6</td>\n",
       "      <td>3</td>\n",
       "      <td>0.000342</td>\n",
       "      <td>523.863636</td>\n",
       "      <td>[NPR2, NPR3, NPPC]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Community_ID  Size  Target_Group_Genes  Global_Adjusted_P_Value  \\\n",
       "25            25     6                   3                 0.000342   \n",
       "\n",
       "    Odds_Ratio   Target_Genes_List  \n",
       "25  523.863636  [NPR2, NPR3, NPPC]  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "GROUP 32: No enriched communities\n",
      "\n",
      "GROUP 33: No enriched communities\n",
      "\n",
      "GROUP 34: No enriched communities\n",
      "\n",
      "GROUP 35: No enriched communities\n",
      "\n",
      "GROUP 36: No enriched communities\n",
      "\n",
      "GROUP 37: No enriched communities\n",
      "\n",
      "GROUP 38 - Enriched communities:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Community_ID</th>\n",
       "      <th>Size</th>\n",
       "      <th>Target_Group_Genes</th>\n",
       "      <th>Global_Adjusted_P_Value</th>\n",
       "      <th>Odds_Ratio</th>\n",
       "      <th>Target_Genes_List</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>53</td>\n",
       "      <td>1687</td>\n",
       "      <td>11</td>\n",
       "      <td>0.034113</td>\n",
       "      <td>6.468735</td>\n",
       "      <td>[TOP2B, PITX1, NIPBL, SALL4, RBPJ, TBX3, NOTCH...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Community_ID  Size  Target_Group_Genes  Global_Adjusted_P_Value  \\\n",
       "53            53  1687                  11                 0.034113   \n",
       "\n",
       "    Odds_Ratio                                  Target_Genes_List  \n",
       "53    6.468735  [TOP2B, PITX1, NIPBL, SALL4, RBPJ, TBX3, NOTCH...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "GROUP 39: No enriched communities\n",
      "\n",
      "GROUP 40: No enriched communities\n",
      "\n",
      "GROUP 41: No enriched communities\n",
      "\n",
      "Global correction applied to 3840 p-values\n"
     ]
    }
   ],
   "source": [
    "disease_groups = sorted(disease_df['group_number'].unique())\n",
    "\n",
    "# Detect communities ONCE\n",
    "print(\"Detecting communities in the PPI network...\")\n",
    "random.seed(42)  # Set seed once\n",
    "communities = list(nx.algorithms.community.louvain_communities(ppi_network))\n",
    "print(f\"Detected {len(communities)} communities in the ppi network graph\")\n",
    "\n",
    "# Collect all results and p-values\n",
    "all_results = {}\n",
    "all_pvalues = [] # p-values for all group-community pairing\n",
    "pvalue_mapping = []\n",
    "\n",
    "for group_num in disease_groups:\n",
    "    print(\"==================================================\")\n",
    "    stats = detect_global_communities_and_analyze_disease_group(ppi_network,\n",
    "                                                                communities,\n",
    "                                                                disease_df,\n",
    "                                                                target_group_number=group_num)\n",
    "    all_results[group_num] = stats\n",
    "    \n",
    "    if stats is not None:\n",
    "        for idx, row in stats.iterrows():\n",
    "            all_pvalues.append(row['Enrichment_P_Value'])\n",
    "            pvalue_mapping.append((group_num, idx))\n",
    "\n",
    "# Apply global correction\n",
    "_, global_corrected_pvals, _, _ = multipletests(all_pvalues, method='fdr_bh')\n",
    "\n",
    "# Update results with global correction\n",
    "for i, (group_num, row_idx) in enumerate(pvalue_mapping):\n",
    "    all_results[group_num].loc[row_idx, 'Global_Adjusted_P_Value'] = global_corrected_pvals[i]\n",
    "\n",
    "# Display results\n",
    "print(\"\\n\" + \"=\"*60)\n",
    "print(\"RESULTS AFTER GLOBAL P-VALUE CORRECTION\")\n",
    "print(\"=\"*60)\n",
    "\n",
    "for group_num in disease_groups:\n",
    "    stats = all_results[group_num]\n",
    "    if stats is not None:\n",
    "        enriched = stats[stats['Global_Adjusted_P_Value'] < 0.05]\n",
    "        if not enriched.empty:\n",
    "            print(f\"\\nGROUP {group_num} - Enriched communities:\")\n",
    "            display(enriched[['Community_ID', 'Size', 'Target_Group_Genes', \n",
    "                           'Global_Adjusted_P_Value', 'Odds_Ratio', 'Target_Genes_List']])\n",
    "        else:\n",
    "            print(f\"\\nGROUP {group_num}: No enriched communities\")\n",
    "\n",
    "print(f\"\\nGlobal correction applied to {len(all_pvalues)} p-values\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "3eae71d0-b3b1-4a2d-b757-d359cd71977c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Enrichment Analysis Results:\n",
      "========================================\n",
      "Total communities tested: 3840\n",
      "Significantly enriched (p < 0.05): 6 (0.2%)\n",
      "\n",
      "Most enriched communities:\n",
      "1. Group 10, Community 7: OR = 38.90, p = 5.19e-17\n",
      "2. Group 31, Community 25: OR = 523.86, p = 3.42e-04\n",
      "3. Group 22, Community 3: OR = 22.92, p = 7.77e-04\n"
     ]
    }
   ],
   "source": [
    "def create_volcano_plot(all_results, disease_groups, figsize=(12, 8)):\n",
    "    \"\"\"\n",
    "    Create a focused plot for community enrichment analysis\n",
    "    Each point represents the enrichment test for one disease-group-community pair\n",
    "    \"\"\"\n",
    "    \n",
    "    # Collect data\n",
    "    plot_data = []\n",
    "    \n",
    "    for group_num in disease_groups:\n",
    "        stats = all_results[group_num]\n",
    "        if stats is not None and not stats.empty:\n",
    "            for idx, row in stats.iterrows():\n",
    "                # Handle undefined edge cases for log transformation\n",
    "                odds_ratio = max(row['Odds_Ratio'], 1e-10)  # Avoid log(0)\n",
    "                p_value = max(row['Global_Adjusted_P_Value'], 1e-50)  # Avoid log(0)\n",
    "                \n",
    "                plot_data.append({\n",
    "                    'Disease_Group': group_num,\n",
    "                    'Community_ID': row['Community_ID'],\n",
    "                    'Odds_Ratio': odds_ratio,\n",
    "                    'Global_Adjusted_P_Value': p_value,\n",
    "                    'Log2_Odds_Ratio': np.log2(odds_ratio),\n",
    "                    'Neg_Log10_P': -np.log10(p_value),  # Keep log10 for p-values\n",
    "                    'Significant': p_value < 0.05,\n",
    "                    'Community_Size': row['Size'],\n",
    "                    'Target_Group_Genes': row['Target_Group_Genes']\n",
    "                })\n",
    "    \n",
    "    if not plot_data:\n",
    "        print(\"No data available for plotting\")\n",
    "        return\n",
    "    \n",
    "    df_plot = pd.DataFrame(plot_data)\n",
    "    \n",
    "    # Create the volcano plot\n",
    "    fig, ax = plt.subplots(figsize=figsize)\n",
    "    \n",
    "    # Define colors for each disease group\n",
    "    unique_groups = sorted(df_plot['Disease_Group'].unique())\n",
    "    colors = plt.cm.Set1(np.linspace(0, 1, len(unique_groups)))\n",
    "    color_map = dict(zip(unique_groups, colors))\n",
    "    \n",
    "    # Plot each disease group separately for better legend\n",
    "    for group in unique_groups:\n",
    "        group_data = df_plot[df_plot['Disease_Group'] == group]\n",
    "        \n",
    "        # Separate significant and non-significant\n",
    "        sig_data = group_data[group_data['Significant']]\n",
    "        non_sig_data = group_data[~group_data['Significant']]\n",
    "        \n",
    "        # Plot non-significant points (smaller, transparent)\n",
    "        if not non_sig_data.empty:\n",
    "            ax.scatter(non_sig_data['Log2_Odds_Ratio'], \n",
    "                      non_sig_data['Neg_Log10_P'],  # Use log10\n",
    "                      c=[color_map[group]], alpha=0.3, s=30,\n",
    "                      marker='o', edgecolors='none')\n",
    "        \n",
    "        # Plot significant points (larger, opaque)\n",
    "        if not sig_data.empty:\n",
    "            ax.scatter(sig_data['Log2_Odds_Ratio'], \n",
    "                      sig_data['Neg_Log10_P'],  # Use log10\n",
    "                      c=[color_map[group]], alpha=0.8, s=80,\n",
    "                      marker='o', edgecolors='black', linewidth=0.5,\n",
    "                      label=f'Group {group}')\n",
    "    \n",
    "    # Add significance threshold line (optional but recommended)\n",
    "    ax.axhline(y=-np.log10(0.05), color='red', linestyle='--', \n",
    "               alpha=0.7, label='p = 0.05')\n",
    "    ax.axvline(x=0, color='black', linestyle='-', alpha=0.3)\n",
    "    \n",
    "    # Customize the plot\n",
    "    ax.set_xlabel('Log₂(Odds Ratio)', fontsize=12)\n",
    "    ax.set_ylabel('-Log₁₀(Adjusted P-value)', fontsize=12)  # Keep log10\n",
    "    ax.set_title('Community Enrichment Analysis', fontsize=14, fontweight='bold')\n",
    "    \n",
    "    # Add grid and legend\n",
    "    ax.grid(True, alpha=0.3)\n",
    "    \n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "    \n",
    "    # Print key statistics\n",
    "    n_total = len(df_plot)\n",
    "    n_significant = len(df_plot[df_plot['Significant']])\n",
    "    \n",
    "    print(f\"\\nEnrichment Analysis Results:\")\n",
    "    print(f\"{'='*40}\")\n",
    "    print(f\"Total communities tested: {n_total}\")\n",
    "    print(f\"Significantly enriched (p < 0.05): {n_significant} ({n_significant/n_total*100:.1f}%)\")\n",
    "    \n",
    "    if n_significant > 0:\n",
    "        print(f\"\\nMost enriched communities:\")\n",
    "        top_results = df_plot[df_plot['Significant']].nsmallest(3, 'Global_Adjusted_P_Value')\n",
    "        for i, (_, row) in enumerate(top_results.iterrows(), 1):\n",
    "            print(f\"{i}. Group {row['Disease_Group']}, Community {row['Community_ID']}: \"\n",
    "                  f\"OR = {row['Odds_Ratio']:.2f}, p = {row['Global_Adjusted_P_Value']:.2e}\")\n",
    "\n",
    "create_volcano_plot(all_results, disease_groups)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d615a7b7-3f68-4de0-91e9-045f3104de8b",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
